| Analysis | Samples | Factors | Units |
|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 16 | Genotype:BE 1 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 26 | Genotype:BE 1 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 27 | Genotype:BE 1 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 04 | Genotype:BE 2 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 07 | Genotype:BE 2 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 32 | Genotype:BE 2 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 05 | Genotype:CHLA 122 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 12 | Genotype:CHLA 122 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 19 | Genotype:CHLA 122 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 29 | Genotype:CHLA 122 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 02 | Genotype:CHLA 136 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 08 | Genotype:CHLA 136 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 15 | Genotype:CHLA 136 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 31 | Genotype:CHLA 136 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 06 | Genotype:CHLA 15 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 10 | Genotype:CHLA 15 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 20 | Genotype:CHLA 15 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 22 | Genotype:CHLA 15 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 11 | Genotype:CHLA 20 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 18 | Genotype:CHLA 20 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 21 | Genotype:CHLA 20 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 03 | Genotype:COGN 144 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 13 | Genotype:COGN 144 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 28 | Genotype:COGN 144 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 30 | Genotype:COGN 144 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 14 | Genotype:COGN 145 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 23 | Genotype:COGN 145 | uM |
| Reversed phase POSITIVE ION MODE | 2021_06_16_Jorida_Run 24 | Genotype:COGN 145 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 16 | Genotype:BE 1 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 26 | Genotype:BE 1 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 27 | Genotype:BE 1 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 04 | Genotype:BE 2 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 07 | Genotype:BE 2 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 32 | Genotype:BE 2 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 05 | Genotype:CHLA 122 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 12 | Genotype:CHLA 122 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 19 | Genotype:CHLA 122 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 29 | Genotype:CHLA 122 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 02 | Genotype:CHLA 136 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 08 | Genotype:CHLA 136 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 15 | Genotype:CHLA 136 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 31 | Genotype:CHLA 136 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 06 | Genotype:CHLA 15 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 10 | Genotype:CHLA 15 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 20 | Genotype:CHLA 15 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 22 | Genotype:CHLA 15 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 11 | Genotype:CHLA 20 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 18 | Genotype:CHLA 20 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 21 | Genotype:CHLA 20 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 03 | Genotype:COGN 144 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 13 | Genotype:COGN 144 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 28 | Genotype:COGN 144 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 30 | Genotype:COGN 144 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 14 | Genotype:COGN 145 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 23 | Genotype:COGN 145 | uM |
| Reversed phase NEGATIVE ION MODE | 2021_06_16_Jorida_Run 24 | Genotype:COGN 145 | uM |
Return to study ST002054 main page
Download data matrix(Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance Reversed phase POSITIVE ION MODE)
Download data matrix(Reduced ER-mitochondria connectivity promotes neuroblastoma multidrug resistance Reversed phase NEGATIVE ION MODE)
- Metabolomics Workbench
|